Mechanism of action and advantages over ACE inhibitors
Sartans act as direct antagonists of type 1 angiotensin II receptors (AT1). Unlike ACE inhibitors, which block only a single synthesis pathway in the vascular bed, AT1 receptor blockers comprehensively eliminate the effects of angiotensin II.
Angiotensin II can be formed not only systemically but also in tissues via alternative enzymatic pathways independent of ACE, and can also enter the bloodstream in its active form. Drugs of this group block receptors directly, eliminating the vasospastic action of angiotensin II regardless of its source.
Hemodynamic effects and impact on the hormonal profile
The pharmacological action of sartans on the cardiovascular system is realized through several key links:
- Direct blockade of vascular AT1 receptors prevents vasospasm.
- Decrease in total peripheral vascular resistance (TPVR).
- Sustained decrease in blood pressure.
- Effect on the adrenal cortex, where receptor blockade leads to the inhibition of aldosterone secretion.
Clinical application and safety profile
Due to their pharmacodynamics, sartans have found wide application in clinical practice. The main indications for their prescription are arterial hypertension and chronic heart failure.
The class is characterized by excellent tolerability and a favorable safety profile. Nevertheless, adverse reactions may develop during pharmacotherapy:
- Central nervous system: headache, dizziness, general weakness.
- Allergic manifestations: a rare but dangerous complication is angioedema.
"Guardian" sartans: they block AT1 receptors tightly, cutting off any alternative pathways for angiotensin II bypassing ACE.
Class and exam questions
What is the main advantage of sartans over ACE inhibitors?
Sartans provide a more complete blockade of angiotensin II. ACE inhibitors block only the systemic pathway of formation, leaving tissue synthesis active, whereas receptor blockers eliminate the effects of angiotensin II regardless of their pathways of appearance.
How do sartans affect aldosterone levels?
The drugs block AT1 receptors in the adrenal cortex, which leads to a predictable decrease in aldosterone secretion.
What are the main indications for prescribing this drug class?
The main clinical indications are arterial hypertension and chronic heart failure.
What else to study on this topic
- Characteristics of individual ARB drugs
- Comparative analysis of side effects with ACE inhibitors
- Pharmacokinetic features of representatives (Losartan, Valsartan, etc.)
- The role of the tissue renin-angiotensin-aldosterone system
- Impact of AT1 receptor blockers on target organs in hypertension
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Angiotensin II Receptor Blockers" and another 5,304 pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Cardiovascular Drugs"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.